With the development of resistance to chemotherapy drugs of basic breast cancer therapy, which is associated with an increase in the expression of genes of the ABC transporter family [24], drugs belonging to the group of antimetabolites, a subgroup of pyrimidine antagonists, may be effective. This evidence concerns the gene ABCG2 and breast cancer.